User profiles for Maryam Oskoui

Maryam Oskoui

Associate Professor, McGill University
Verified email at mcgill.ca
Cited by 10607

An update on the prevalence of cerebral palsy: a systematic review and meta‐analysis

M Oskoui, F Coutinho, J Dykeman… - … Medicine & Child …, 2013 - Wiley Online Library
Aims The aim of this study was to provide a comprehensive update on (1) the overall prevalence
of cerebral palsy ( CP ); (2) the prevalence of CP in relation to birthweight; and (3) the …

Observational study of spinal muscular atrophy type I and implications for clinical trials

…, PB Kang, AR Foley, ML Yang, WB Martens, M Oskoui… - Neurology, 2014 - AAN Enterprises
Objectives: Prospective cohort study to characterize the clinical features and course of
spinal muscular atrophy type I (SMA-I). Methods: Patients were enrolled at 3 study sites and …

Screening for developmental delay in the setting of a community pediatric clinic: a prospective assessment of parent-report questionnaires

D Rydz, M Srour, M Oskoui, N Marget, M Shiller… - …, 2006 - publications.aap.org
OBJECTIVES. Our goal for this study was to prospectively test whether parent-completed
questionnaires can be effectively used in the setting of a busy ambulatory pediatric clinic to …

Topical review: developmental screening

…, MI Shevell, A Majnemer, M Oskoui - Journal of child …, 2005 - journals.sagepub.com
An estimated 5 to 10% of the pediatric population has a developmental disability. The current
strategy to identify these children is through developmental surveillance, a continuous …

Practice guideline recommendations summary: treatment of tics in people with Tourette syndrome and chronic tic disorders

…, M Robinson, E Jarvie, V Roessner, M Oskoui… - Neurology, 2019 - AAN Enterprises
Objective To make recommendations on the assessment and management of tics in people
with Tourette syndrome and chronic tic disorders. Methods A multidisciplinary panel …

An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients

…, WB Martens, C Annis, R Tawil, M Oskoui… - Neuromuscular …, 2007 - Elsevier
PURPOSE: To develop and evaluate an expanded version of the Hammersmith Functional
Motor Scale allowing for evaluation of ambulatory SMA patients. PROCEDURES: Thirty-eight …

Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy: Report of the Guideline Development Subcommittee of the American …

D Gloss, RT Moxley III, S Ashwal, M Oskoui - Neurology, 2016 - AAN Enterprises
Maryam Oskoui has received travel funding from the AAN (to attend the Guideline
Development Subcommittee meetings) and Isis Pharmaceuticals (to attend investigator meetings …

Prospective cohort study of spinal muscular atrophy types 2 and 3

…, RS Finkel, DM Sproule, PB Kang, M Oskoui… - Neurology, 2012 - AAN Enterprises
Objective: To characterize the natural history of spinal muscular atrophy type 2 and type 3 (SMA
2/3) beyond 1 year and to report data on clinical and biological outcomes for use in trial …

Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go

…, K Nkole, G O'Grady, D O'Rourke, M Oskoui… - Neuromuscular …, 2021 - Elsevier
Spinal muscular atrophy (SMA) is a rare and devastating disease. New disease-modifying
treatments have recently been approved and early treatment has been related to a better …

Global prevalence of cerebral palsy: A systematic analysis

…, H Smithers‐Sheedy, M Oskoui… - … Medicine & Child …, 2022 - Wiley Online Library
Aim To determine trends and current estimates in regional and global prevalence of
cerebral palsy (CP). Method A systematic analysis of data from participating CP registers/…